Ipratropium Bromide (Watson Laboratories, Inc.)
Welcome to the PulseAid listing for the Ipratropium Bromide drug offered from Watson Laboratories, Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Watson Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Ipratropium Bromide |
| SUBSTANCE NAME: | IPRATROPIUM BROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Ipratropium Bromide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ipratropium Bromide from Watson Laboratories, Inc. |
| LABELER NAME: | Watson Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/2.5mL) |
| START MARKETING DATE: | 2011-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3798_b82da04a-7b9f-4726-aece-cb2f263401df |
| PRODUCT NDC: | 0591-3798 |
| APPLICATION NUMBER: | ANDA075693 |
Other IPRATROPIUM BROMIDE Pharmaceutical Manufacturers / Labelers:
